Section 6
Chapter 5,527

Glucokinase in beta cell depleted islets of langerhans

Bedoya, F.J.; Oberholtzer, J.C.; Matschinsky, F.M.

Journal of Histochemistry and Cytochemistry 35(10): 1089-1094


ISSN/ISBN: 0022-1554
Accession: 005526948

Glucose phosphorylation was studied in B-cell-enriched or in B-cell-depleted pancreatic islets from normal or streptozotocin-diabetic rats, respectively, using quantitative histochemical proceudres. The data indicate that B-cell-enriched preparations from normal animals and whole islets from normals, diabetics, and insulin-treated diabetic animals have comparable glucokinase activities. average maximum velocities were (mmol/kg dry tissue/hr) 134.1 .+-. 7.3 for whole islets and 125.6 .+-. 10.7 for the B-cell-enriched preparations from normal rats, 143.1 .+-. 13.6 for B-cell-depleted islets from diabetic rats, and 124.4 .+-. 10.7 for B-cell-depleted islets from insulin-treated diabetic animals. The Kmax for glucose of the enzyme in islets from untreated diabetic rats was 16 mM, comparable to the Kmax found for glucokinase from normal rat islets. Mannoheptulose, previously showed to be a competitive inhibitor of glucokinase from liver and normal islets, also inhibited glucokinase in B-cell-depleted islets form diabetic rats. The data indicate that glucokinase is not selectively located in the B-cell, as was previously assumed, but is also found in A- and/or D-cells of diabetic rats. This observation raises significant questions about the functional role of islet glucokinase under control and diabetic conditions.

PDF emailed within 1 workday: $29.90